Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1156 per EA under NDC 75834024701. Its NADAC has been published 124 times since Feb 14, 2024.
Strength
2.5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834024701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA211298On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1156 per EA |
|---|---|
| All-time high | $0.2190 (Mar 13, 2024) |
| All-time low | $0.0828 (Jul 17, 2024) |
| 52-week high | $0.1334 |
| 52-week low | $0.1156 |
| Median price | $0.1236 |
| Average price | $0.1248 |
| Largest weekly change | +53.6% (Aug 21, 2024) |
| Weeks tracked | 124 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1156 per EA (NDC 75834024701), effective Jun 24, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 31.7%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Feb 14, 2024, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2190 (Mar 13, 2024), with a median of $0.1236 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 3% below TADALAFIL 2.5 MG TABLET.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 75834024701) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification